Literature DB >> 16908717

Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus.

S A Harding, J Sarma, J N Din, P M Maciocia, D E Newby, K A A Fox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16908717      PMCID： PMC1861162          DOI： 10.1136/hrt.2005.083006

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

Review 1.  RANTES: a versatile and controversial chemokine.

Authors:  V Appay; S L Rowland-Jones
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

Review 2.  The role of adenosine 5'-diphosphate receptor blockade in patients with cardiovascular disease.

Authors:  D J Solet; L R Zacharski; J F Plehn
Journal:  Am J Med       Date:  2001-07       Impact factor: 4.965

Review 3.  Role of platelets in the development of atherosclerosis.

Authors:  Yuqing Huo; Klaus F Ley
Journal:  Trends Cardiovasc Med       Date:  2004-01       Impact factor: 6.677

4.  Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.

Authors:  Zihui Xiao; Pierre Théroux
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

5.  Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.

Authors:  Martin J Quinn; Deepak L Bhatt; Frank Zidar; Deepak Vivekananthan; Derek P Chew; Stephen G Ellis; Edward Plow; Eric J Topol
Journal:  Am J Cardiol       Date:  2004-03-15       Impact factor: 2.778
  5 in total
  8 in total

Review 1.  Beyond platelet inhibition: potential pleiotropic effects of ADP-receptor antagonists.

Authors:  Srinivas Iyengar; LeRoy E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2008-04-09       Impact factor: 2.300

2.  N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.

Authors:  A T Treweeke; T J Winterburn; I Mackenzie; F Barrett; C Barr; G F Rushworth; I Dransfield; S M MacRury; I L Megson
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

Review 3.  Platelets and their chemokines in atherosclerosis-clinical applications.

Authors:  Philipp von Hundelshausen; Martin M N Schmitt
Journal:  Front Physiol       Date:  2014-08-08       Impact factor: 4.566

4.  Fire Simulation and Cardiovascular Health in Firefighters.

Authors:  Amanda L Hunter; Anoop S V Shah; Jeremy P Langrish; Jennifer B Raftis; Andrew J Lucking; Mairi Brittan; Sowmya Venkatasubramanian; Catherine L Stables; Dominik Stelzle; James Marshall; Richard Graveling; Andrew D Flapan; David E Newby; Nicholas L Mills
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

5.  The synergistic effects of clopidogrel with montelukast may be beneficial for asthma treatment.

Authors:  Hoang Kim Tu Trinh; Thuy Van Thao Nguyen; Youngwoo Choi; Hae-Sim Park; Yoo Seob Shin
Journal:  J Cell Mol Med       Date:  2019-03-23       Impact factor: 5.310

6.  Combined Antiplatelet Therapy Reduces the Proinflammatory Properties of Activated Platelets.

Authors:  Alexandra C A Heinzmann; Daniëlle M Coenen; Tanja Vajen; Judith M E M Cosemans; Rory R Koenen
Journal:  TH Open       Date:  2021-10-28

7.  Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study.

Authors:  Gareth J Padfield; Jehangir N Din; Elena Koushiappi; Nicholas L Mills; Simon D Robinson; Nicholas Le May Cruden; Andrew John Lucking; Stanley Chia; Scott A Harding; David E Newby
Journal:  Heart       Date:  2013-04-10       Impact factor: 7.365

8.  Effect of wood smoke exposure on vascular function and thrombus formation in healthy fire fighters.

Authors:  Amanda L Hunter; Jon Unosson; Jenny A Bosson; Jeremy P Langrish; Jamshid Pourazar; Jennifer B Raftis; Mark R Miller; Andrew J Lucking; Christoffer Boman; Robin Nyström; Kenneth Donaldson; Andrew D Flapan; Anoop S V Shah; Louis Pung; Ioannis Sadiktsis; Silvia Masala; Roger Westerholm; Thomas Sandström; Anders Blomberg; David E Newby; Nicholas L Mills
Journal:  Part Fibre Toxicol       Date:  2014-12-09       Impact factor: 9.400
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.